In this article
Copper peptides are one of the most talked-about ingredients in skin care. You will see claims that they rebuild collagen, firm skin, and reverse aging. Some of that comes from real laboratory science. Much less of it has been shown in well-designed studies of people. This guide explains what GHK-Cu is, what has been tested, and where the honest answer is that nobody knows yet.
What GHK-Cu is
GHK stands for glycyl-L-histidyl-L-lysine. It is a small, naturally occurring copper-binding peptide made of three amino acids, and GHK-Cu is its copper-bound form [1]. It is present in human blood plasma and can be released from tissue after an injury [1].
A review by the scientist who discovered the peptide reports that plasma GHK is about 200 ng/mL at age 20 and falls to about 80 ng/mL by age 60 [1]. But a lower blood level with age does not by itself show that putting the peptide on your skin reverses aging.
What lab and animal studies show
In the laboratory, GHK-Cu has many reported effects. The same review describes it stimulating the growth of blood vessels and nerves, increasing collagen, elastin, and glycosaminoglycan production, and supporting the function of dermal fibroblasts, the cells that make collagen [1]. It also reports tissue-repair effects in skin and several other organs [1]. An independent review describes most of this evidence as preclinical [2].
An independent systematic review published in 2026 screened 1,247 records and kept 64 [2]. It agreed that GHK-Cu has a deep and mechanistically coherent body of preclinical evidence, meaning cell, tissue, and animal work [2]. Its main point, though, was the gap: that preclinical promise has not yet been confirmed in well-designed human trials [2].
What human studies show
Here is the human evidence most often quoted, and what is known about each study.
| Study | What was reported | Caveat |
|---|---|---|
| Facial cream, 71 women, 12 weeks [1] | Thicker, denser skin, less laxity, fewer fine lines | Presented at a 2002 dermatology meeting; not published as a full peer-reviewed paper [1, 2] |
| Eye cream, 41 women, 12 weeks [1] | Did better than placebo and a vitamin K cream on lines and wrinkles | Also a 2002 meeting presentation [1, 2] |
| Thigh skin, 12 weeks [1] | More collagen production in 70% of women, vs 50% with vitamin C and 40% with retinoic acid | A small pilot study [1] |
| After CO2 laser resurfacing, 13 patients, randomized [3] | No difference in redness, wrinkles, or skin quality on objective measures; patients using GHK-Cu were more satisfied | Very small, but blinded and randomized [3] |
The facial and eye-cream results sound impressive, and they are widely repeated. But the 2026 systematic review points out that several of the most frequently cited trials, including both 2002 studies, were published only as conference abstracts and have not appeared in full peer-reviewed form [2]. It calls this the principal weakness of the human evidence base [2]. The review also notes that most human studies of GHK-Cu have fewer than 100 participants and last 8 to 16 weeks [2].
The randomized trial after laser resurfacing is the clearest test of GHK-Cu skin care, and it was disappointing on objective outcomes. Thirteen patients were randomized to a regimen with or without GHK-Cu. Blinded evaluators and computer analysis found no significant difference in how quickly redness resolved, in wrinkle improvement, or in overall skin quality [3]. The one difference was that patients using GHK-Cu rated their skin quality as more improved [3].
What is still unknown
Being honest about GHK-Cu means listing the open questions:
- Does it get through your skin? GHK-Cu is a charged, water-loving molecule, and passive movement across intact skin is poor [2]. How much of a cream reaches the cells that make collagen is not well established.
- Who did the research? About 35% of the GHK-Cu studies in the 2026 review include the peptide's discoverer or his colleague as an author, and he held commercial interests in the field for decades [2]. The review calls that work substantive but says it limits the independence of the evidence [2].
- Does it work for women in menopause specifically? None of the human studies above tested GHK-Cu as a treatment for menopausal skin changes.
- What is the right dose? Products and studies vary in formulation and concentration, and a 2026 review of skin peptides warned against assuming results from one peptide product apply to another [4].
- Long-term safety: Studies have run for weeks to a few months [2], so effects of years of use are not known.
A broader 2026 review of peptides used in aesthetic dermatology reached a similar view. It found that controlled human studies report improvements in some skin measures, but that many are limited by small samples, short follow-up, industry sponsorship, or products that mix several ingredients [4].
Safety and regulation
GHK-Cu creams have not been through FDA drug approval. The FDA has flagged one specific use: on a list of bulk substances that may present significant safety risks in compounding, it lists GHK-Cu for injectable routes, noting that compounded injectable GHK-Cu may pose a risk of immune reactions because of aggregation and peptide-related impurities, and that there are limited human data to inform safety [5]. That entry is about injections. The FDA page does not address topical creams [5].
For a cream, the side effects listed in WarriorBabe Health's product information are temporary redness, mild itching, temporary breakouts, and dryness in the first two to three weeks. It also says not to use it if you have Wilson's disease or a known copper allergy, and to tell your clinician before applying it to broken or damaged skin.
GHK-Cu creams through WarriorBabe Health
WarriorBabe Health offers a GHK-Cu copper peptide cream at 1% strength. Its directions are a pea-sized amount once daily on clean, dry skin of the face, neck, or chest, or another area your provider directs. GHK-Cu is also one of four ingredients in the estriol + niacinamide + GHK-Cu + hyaluronic acid cream, which contains a mild estrogen. You can read about that ingredient in our guide to estriol cream for the face.
Both are compounded by a licensed pharmacy and are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed [6]. Given how thin the human evidence is, think of GHK-Cu as an option to try with realistic expectations, not as a proven fix, and keep daily sun protection as the base of any skin plan.
If you want to talk through options, compare products on our skin treatments page, read about menopause skin changes, or take the 2-minute quiz. A licensed clinician reviews your answers and health history before anything is prescribed.
Frequently asked questions
What does GHK-Cu do for skin?
In lab and animal studies, GHK-Cu increases collagen and elastin production and supports skin repair [1]. In people, the evidence is thin: most trials are small, several were never published in full [2], and the one randomized trial after laser resurfacing found no objective improvement in wrinkles or skin quality [3].
Is GHK-Cu proven to reduce wrinkles?
No. Reports of fewer wrinkles come from small studies, including two presented at a 2002 meeting that have not appeared as full peer-reviewed papers [1, 2]. A 2026 systematic review concluded that well-designed human trials are still needed [2].
Is copper peptide safe to use on my face?
Human studies have lasted weeks to a few months, so long-term safety is not known [2]. Our product information lists temporary redness, itching, breakouts, and dryness, and says not to use it with Wilson's disease or a copper allergy. The FDA's safety concern listed for GHK-Cu applies to compounded injections [5].
Why does GHK-Cu decline with age?
A review by the peptide's discoverer reports blood levels of about 200 ng/mL at age 20 and 80 ng/mL by 60 [1]. Why it falls is not established, and a lower blood level does not show that applying it to skin reverses aging.
Is a GHK-Cu cream FDA-approved?
No. Compounded GHK-Cu creams are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed [6]. The FDA has separately flagged compounded GHK-Cu injections for possible immune reactions and limited human safety data [5].
References
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
- Najafi N, Maatouk H, Vardanyan KG, Vartanian KB, Agrawal DK. A systematic review of the mechanisms and therapeutic applications of GHK-Cu (glycyl-L-histidyl-L-lysine-copper complex) in topical and surgical applications: the case for expanded clinical trials. Arch Intern Med Res. 2026;9(3):269-293. pmc.ncbi.nlm.nih.gov/articles/PMC13604022/
- Miller TR, Wagner JD, Baack BR, Eisbach KJ. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-259. pubmed.ncbi.nlm.nih.gov/16847171/
- Yi KH, Kim HS, Lee HE, Choi WS, Kim JH. Peptides in aesthetic dermatology: classification, fibroblast-centered mechanisms, delivery technologies, and clinical evidence. Life (Basel). 2026;16(10):1660. pubmed.ncbi.nlm.nih.gov/42942246/
- US Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. 2026. www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- US Food and Drug Administration. Understanding the risks of compounded drugs. www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs
This article is for general information. It is not medical advice and does not replace a visit with a licensed clinician who knows your history. Do not start, stop or change a medication without talking to your clinician. If you think you are having a medical emergency, call 911.
